Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset

Autoimmunity

Volumn 38, Issue 8, 2005, Pages 567-575

  Bekris, Lynn M ^a   Shephard, Cindy ^a   Peterson, Morgan ^a   Hoehna, Jana ^a   Van Yserloo, Brian ^a   Rutledge, Elizabeth ^a   Farin, Federico ^a   Kavanagh, Terrance J ^a   Lernmark, Ake ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Age at onset; Glutathione s transferase; GSTM1; GSTT1; Polymorphism; Type 1 diabetes

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; ONSET AGE; REFERENCE VALUE; REGISTER; SWEDEN;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; GLUTATHIONE TRANSFERASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFANT; INFANT, NEWBORN; ISOENZYMES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEX FACTORS;

EID: 30844448323     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930500407238     Document Type: Article

References (96)

1. Atkinson, MA and Eisenbarth, GS. (2001) Type 1 diabetes: New perspectives on disease pathogenesis and treatment Lancet, 358, pp. 221-229.
2. Mathis, D and Vence, L and Benoist, C. (2001) Beta-cell death during progression to diabetes Nature, 414, pp. 792-798.
3. Graham, J and Hagopian, WA and Kockum, I and Li, LS and Sanjeevi, CB and Lowe, RM and Schaefer, JB and Zarghami, M and Day, HL and Landin-Olsson, M and Palmer, JP and Janer-Villanueva, M and Hood, L and Sundkvist, G and Lernmark, A and Breslow, N and Dahlquist, G and Blohme, G. (2002) Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes Diabetes, 51, pp. 1346-1355.
4. Blohmé, G and Nyström, L and Arnqvist, HJ and Lithner, F and Littorin, B and Olsson, PO and Scherstén, B and Wibell, L and Ostman, J. (1992) Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adult: Results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden Diabetologia, 35, pp. 55-62.
5. Karvonen, M and Viik-Kajander, M and Moltchanova, E and Libman, I and LaPorte, R and Tuomilehjto, J. (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) project group Diabetes Care, 23, pp. 1516-1526.
6. Weets, I and Van Autreve, J and Van der Auwera, BJ and Schuit, FC and Du Caju, MV and Decochez, K and De Leeuw, IH and Keymeulen, B and Mathieu, C and Rottiers, R and Dorchy, H and Quartier, E and Gorus, FK. (2001) Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index Diabetologia, 44, pp. 40-47.
7. Weets, I and Kaufman, L and Van Der Auwera, B and Crenier, L and Rooman, RP and De Block, C and Casteels, K and Weber, E and Coeckelberghs, M and Laron, Z and Pipeleers, DG and Gorus, FK. (2004) Seasonality in clinical onset of type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence Diabetologia, 26, pp. 26.
8. Akerblom, HK and Vaarala, O and Hyoty, H and Ilonen, J and Knip, M. (2002) Environmental factors in the etiology of type 1 diabetes Am J Med Genet, 115, pp. 18-29.
9. Schrezenmeir, J and Jagla, A. (2000) Milk and diabetes J Am Coll Nutr, 19, pp. 176S-190S.
10. Longnecker, MP and Daniels, JL. (2001) Environmental contaminants as etiologic factors for diabetes Environ Health Perspect, 109, pp. 871-876.
11. Couper, JJ. (2001) Environmental triggers of type 1 diabetes J Paediatr Child Health, 37, pp. 218-220.
12. Sanjeevi, CB and Höök, P and Landin-Olsson, M and Kockum, I and Dahlquist, G and Lybrand, TP and Lernmark, Å. (1996) DR4 subtypes and their molecular properties in a population base study of Swedish childhood diabetes Tissue Antigens, 47, pp. 275-283.
13. Pociot, F and McDermott, MF. (2002) Genetics of type 1 diabetes mellitus Genes Immun, 3, pp. 235-249.
14. Bennett, ST and Wilson, AJ and Cucca, F and Nerup, J and Pociot, F and McKinney, PA and Barnett, AH and Bain, SC and Todd, JA. (1996) IDDM2-VNTR-encoded susceptibility to type 1 diabetes: Dominant protection and parental transmission of allele of the insulin gene-linked minisatellite locus J Autoimmunity, 9, pp. 415-421.
15. Pugliese, A and Miceli, D. (2002) The insulin gene in diabetes Diabetes Metab Res Rev, 18, pp. 13-25.
16. Lowe, RM and Graham, J and Sund, G and Kockum, I and Landin-Olsson, M and Schaefer, JB and Torn, C and Lernmark, A and Dahlquist, G. (2000) The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes Autoimmunity, 32, pp. 173-180.
17. Kristiansen, OP and Larsen, ZM and Pociot, F. (2000) CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun, 1, pp. 170-184.
18. Kyvik, KO and Green, A and Beck, NH. (1995) Concordance rates of insulin dependent diabetes mellitus: A population based study of young Danish twins BMJ, 311, pp. 913-917. [see comments]
19. Kaprio, J and Tuomilehto, J and Koskenvuo, M and Romanov, K Reunanen, A and Eriksson, J and Stengård J and Kesäniemi, YA. (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland Diabetologia, 35, pp. 1060-1067.
20. LaGasse, JM and Brantley, MS and Leech, NJ and Rowe, RE and Monks, S and Palmer, JP and Nepom, GT and McCulloch, DK and Hagopian, WA. (2002) Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: An 8-year follow-up of the Washington State Diabetes Prediction Study Diabetes Care, 25, pp. 505-511.
21. Greenbaum, CJ and Sears, KL and Kahn, SE and Palmer, JP. (1999) Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes-Follow-up of the Seattle Family Study Diabetes, 48, pp. 170-175.
22. Bonifacio, E and Bingley, PJ and Shattock, M and Dean, BM and Dunger, D and Gale, EAM and Bottazzo, GF. (1990) Quantification of islet cell antibodies and prediction of insulin dependent diabetes Lancet, 335, pp. 147-149.
23. Verge, CF and Gianani, R and Yu, L and Pietropaolo, M and Smith, T and Jackson, RA and Soeldner, JS and Eisenbarth, GS. (1995) Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes Diabetes, 44, pp. 1176-1179.
24. Petersen, JS and Kyvik, KO and Bingley, PJ and Gale, EA and Green, A and Dyrberg, T and Beck, NH. (1997) Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus BMJ, 314, pp. 1575-1579.
25. Redondo, MJ and Rewers, M and Yu, L and Garg, S and Pilcher, CC and Elliott, RB and Eisenbarth, GS. (1999) Genetic determination of islet cell autoimmunity in monozygotic twin BMJ, 318, pp. 698-702.
26. Fava, D and Gardner, S and Pyke, D and Leslie, RD. (1998) Evidence that the age at diagnosis of IDDM is genetically determined Diabetes Care, 21, pp. 925-929.
27. Gale, EA and Gillespie, KM. (2001) Diabetes and gender Diabetologia, 44, pp. 3-15.
28. Ho, E and Bray, TM. (1999) Antioxidants, NFkappaB activation, and diabetogenesis Proc Soc Exp Biol Med, 222, pp. 205-213.
29. West, IC. (2000) Radicals and oxidative stress in diabetes Diabet Med, 17, pp. 171-180.
30. Dierckx, N and Horvath, G and van Gils, C and Vertommen, J and van de Vliet, J and De Leeuw, I and Manuel-y-Keenoy, B. (2003) Oxidative stress status in patients with diabetes mellitus: Relationship to diet Eur J Clin Nutr, 57, pp. 999-1008.
31. Elhadd, TA and Kennedy, G and Hill, A and McLaren, M and Newton, RW and Greene, SA and Belch, JJ. (1999) Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease Diabetes Metab Res Rev, 15, pp. 405-411.
32. Martin-Gallan, P and Carrascosa, A and Gussinye, M and Dominguez, C. (2003) Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications Free Radic Biol Med, 34, pp. 1563-1574.
33. Varvarovska, J and Racek, J and Stozicky, F and Soucek, J and Trefil, L and Pomahacova, R. (2003) Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives J Diabetes Complications, 17, pp. 7-10.
34. Rocic, B and Vucic, M and Knezevic-Cuca, J and Radica, A and Pavlic-Renar, I and Profozic, V and Metelko, Z. (1997) Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes Exp Clin Endocrinol Diabetes, 105, pp. 213-217.
35. Ho, E and Chen, G and Bray, TM. (1999) Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice FASEB J, 13, pp. 1845-1854.
36. Tran, PO and Parker, SM and LeRoy, E and Franklin, CC and Kavanagh, TJ and Zhang, T and Zhou, H and Vliet, P and Oseid, E and Harmon, JS and Robertson, RP. (2004) Adenoviral overexpression of the glutamylcysteine ligase catalytic subunit protects pancreatic islets against oxidative stress J Biol Chem, 279, pp. 53988-53993. Epub 52004 Oct 53912
37. Hayes, JD and Strange, RC. (2000) Glutathione S-transferase polymorphisms and their biological consequences Pharmacology, 61, pp. 154-166.
38. Hayes, JD and McLellan, LI. (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress Free Radic Res, 31, pp. 273-300.
39. Eaton, DL and Bammler, TK. (1999) Concise review of the glutathione S-transferases and their significance to toxicology Toxicol Sci, 49, pp. 156-164.
40. Landi, S. (2000) Mammalian class theta GST and differential susceptibility to carcinogens: A review Mutat Res, 463, pp. 247-283.
41. de Bruin, WC and Wagenmans, MJ and Peters, WH. (2000) Expression of glutathione S-transferase alpha, P1-1 and T1-1 in the human gastrointestinal tract Jpn J Cancer Res, 91, pp. 310-316.
42. Standop, J and Ulrich, AB and Schneider, MB and Buchler, MW and Pour, PM. (2002) Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas Pancreatology, 2, pp. 510-518.
43. Ulrich, AB and Schmied, BM and Standop, J and Schneider, MB and Lawson, TA and Friess, H and Andren-Sandberg, A and Buchler, MW and Pour, PM. (2002) Differences in the expression of glutathione S-transferases in normal pancreas, chronic pancreatitis, secondary chronic pancreatitis, and pancreatic cancer Pancreas, 24, pp. 291-297.
44. Verlaan, M and te Morsche, RH and Roelofs, HM and Laheij, RJ and Jansen, JB and Peters, WH and Drenth, JP. (2003) Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis Am J Med Genet A, 120, pp. 34-39.
45. Yuille, M and Condie, A and Hudson, C and Kote-Jarai, Z and Stone, E and Eeles, R and Matutes, E and Catovsky, D and Houlston, R. (2002) Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia Blood, 99, pp. 4216-4218.
46. Rollinson, S and Roddam, P and Kane, E and Roman, E and Cartwright, R and Jack, A and Morgan, GJ. (2000) Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia Carcinogenesis, 21, pp. 43-47.
47. Wenzlaff, AS and Cote, ML and Bock, CH and Land, SJ and Schwartz, AG. (2005) GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: A population-based study Carcinogenesis, 26, pp. 395-401. Epub 2004 Nov 2004
48. de Jong, MM and Nolte, IM and te Meerman, GJ and van der Graaf, WT and de Vries, EG and Sijmons, RH and Hofstra, RM and Kleibeuker, JH. (2002) Low-penetrance genes and their involvement in colorectal cancer susceptibility Cancer Epidemiol Biomarkers Prev, 11, pp. 1332-1352.
49. Loktionov, A and Watson, MA and Gunter, M and Stebbings, WS and Speakman, CT and Bingham, SA. (2001) Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: Interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor Carcinogenesis, 22, pp. 1053-1060.
50. Clapper, ML. (2000) Genetic polymorphism and cancer risk Curr Oncol Rep, 2, pp. 251-256.
51. Mattey, DL and Hassell, AB and Dawes, PT and Jones, PW and Yengi, L and Alldersea, J and Strange, RC and Fryer, AA. (2000) Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: Evidence for interaction with glutathione S-transferase genes Arthritis Rheum, 43, pp. 859-864.
52. Mattey, DL and Hutchinson, D and Dawes, PT and Nixon, NB and Clarke, S and Fisher, J and Brownfield, A and Alldersea, J and Fryer, AA and Strange, RC. (2002) Smoking and disease severity in rheumatoid arthritis: Association with polymorphism at the glutathione S-transferase M1 locus Arthritis Rheum, 46, pp. 640-646.
53. Layton, MA and Jones, PW and Alldersea, JE and Strange, RC and Fryer, AA and Dawes, PT and Mattey, DL. (1999) The therapeutic response to D-penicillamine in rheumatoid arthritis: Influence of glutathione S-transferase polymorphisms Rheumatology, 38, pp. 43-47. (Oxford)
54. Brasch-Andersen, C and Christiansen, L and Tan, Q and Haagerup, A and Vestbo, J and Kruse, TA. (2004) Possible gene dosage effect of glutathione-S-transferases on atopic asthma: Using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers Hum Mutat, 24, pp. 208-214.
55. Tamer, L and Calikoglu, M and Ates, NA and Yildirim, H and Ercan, B and Saritas, E and Unlu, A and Atik, U. (2004) Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma Respirology, 9, pp. 493-498.
56. Matheson, MC and Stevenson, T and Akbarzadeh, S and Propert, DN. (2002) GSTT1 null genotype increases risk of premenopausal breast cancer Cancer Lett, 181, pp. 73-79.
57. Mitrunen, K and Hirvonen, A. (2003) Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism Mutat Res, 544, pp. 9-41.
58. Chen, K and Jiang, QT and He, HQ. (2005) Relationship between metabolic enzyme polymorphism and colorectal cancer World J Gastroenterol, 11, pp. 331-335.
59. Lenzen, S and Drinkgern, J and Tiedge, M. (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues Free Radic Biol Med, 20, pp. 463-466.
60. Lortz, S and Tiedge, M and Nachtwey, T and Karlsen, AE and Nerup, J and Lenzen, S. (2000) Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes Diabetes, 49, pp. 1123-1130.
61. Rasilainen, S and Nieminen, JM and Levonen, AL and Otonkoski, T and Lapatto, R. (2002) Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide Biochem Pharmacol, 63, pp. 1297-1304.
62. Bottino, R and Balamurugan, AN and Tse, H and Thirunavukkarasu, C and Ge, X and Profozich, J and Milton, M and Ziegenfuss, A and Trucco, M and Piganelli, JD. (2004) Response of human islets to isolation stress and the effect of antioxidant treatment Diabetes, 53, pp. 2559-2568.
63. Tiedge, M and Lortz, S and Munday, R and Lenzen, S. (1999) Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells Diabetologia, 42, pp. 849-855.
64. Tiedge, M and Lortz, S and Munday, R and Lenzen, S. (1998) Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species Diabetes, 47, pp. 1578-1585.
65. Bastar, I and Seckin, S and Uysal, M and Aykac-Toker, G. (1998) Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats Res Commun Mol Pathol Pharmacol, 102, pp. 265-272.
66. Rabinovitch, A. (1992) Free radicals as mediators of pancreatic islet beta-cell injury in autoimmune diabetes J Lab Clin Med, 119, pp. 455-456.
67. Landin-Olsson, M and Palmer, JP and Lernmark, Å and Blom, L and Sundkvist, G and Nyström, L and Dahlquist, G. (1992) Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children Diabetologia, 35, pp. 1068-1073.
68. Landin-Olsson, M and Karlsson, FA and Lernmark, Å and Sundkvist, G. (1992) Islet cell and thyrogastric antibodies in 633 consecutive 15-34 years old patients in the Diabetes Incidence Study in Sweden (DISS) Diabetes, 41, pp. 1022-1027.
69. Chen, CL and Liu, Q and Relling, MV. (1996) Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks Pharmacogenetics, 6, pp. 187-191.
70. Bell, DA and Taylor, JA and Paulson, DF and Robertson, CN and Mohler, JL and Lucier, GW. (1993) Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer J Natl Cancer Inst, 85, pp. 1159-1164.
71. Pemble, S and Schroeder, KR and Spencer, SR and Meyer, DJ and Hallier, E and Bolt, HM and Ketterer, B and Taylor, JB. (1994) Human glutathione S-transferase theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism Biochem J, 300, pp. 271-276.
72. D'Aquila, RT and Bechtel, LJ and Videler, JA and Eron, JJ and Gorczyca, P and Kaplan, JC. (1991) Maximizing sensitivity and specificity of PCR by pre-amplification heating Nucleic Acids Res, 19, pp. 3749.
73. Grubin, CE and Daniels, T and Toivola, B and Landin-Olsson, M and Hagopian, WA and Li, L and Karlsen, AE and Boel, E and Michelsen, B and Lernmark, Å. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM Diabetologia, 37, pp. 344-350.
74. Falorni, A and Grubin, CE and Takei, I and Shimada, A and Kasuga, A and Maruyama, T and Ozawa, Y and Kasatani, T and Saruta, T and Li, L and Lernmark, Å. (1994) Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes Autoimmunity, 19, pp. 113-125.
75. Gianani, R and Rabin, DU and Verge, CF and Yu, L and Babu, SR and Pietropaolo, M and Eisenbarth, GE. (1995) ICA512 autoantibody radioassay Diabetes, 44, pp. 1340-1344.
76. Rabin, DU and Pleasic, SM and Palmer-Crocker, R and Shapiro, JA. (1992) Cloning and expression of IDDM-specific human autoantigens Diabetes, 41, pp. 183-186.
77. Bonifacio, E and Lernmark, A and Dawkins, RL. (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies J Immunol Methods, 106, pp. 83-88.
78. Dahl-Jørgensen, K and Joner, G and Hanssen, KF. (1991) Relationship between cow's milk consumption and incidence of IDDM in childhood Diabetes Care, 14, pp. 1081-1083.
79. Wasmuth, HE and Kolb, H. (2000) Cow's milk and immune-mediated diabetes Proc Nutr Soc, 59, pp. 573-579.
80. Virtanen, SM and Laara, E and Hypponen, E and Reijonen, H and Rasanen, and L. Aro, A and Knip, M Ilonen, J and Akerblom, HK. (2000) Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: A nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group Diabetes, 49, pp. 912-917.
81. Pundziute-Lycka, A and Persson, LA and Cedermark, G and Jansson-Roth, A and Nilsson, U and Westin, V and Dahlquist, G. (2004) Diet, growth, and the risk for type 1 diabetes in childhood: A matched case-referent study Diabetes Care, 27, pp. 2784-2789.
82. Whincup, PH and Cook, DG and Adshead, F and Taylor, SJ and Walker, M and Papacosta, O and Alberti, KG. (1997) Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11-year-old children Diabetologia, 40, pp. 319-326.
83. Pundziute-Lycka, A and Dahlquist, G and Nystrom, L and Arnqvist, H and Bjork, E and Blohme, G and Bolinder, J and Eriksson, JW and Sundkvist, G and Ostman, J and Pundziute-Lycka, GA and (2002) The Swedish Childhood Diabetes Study: Type I diabetes in the 0-34 years group in Sweden Diabetologia, 45, pp. 783-791.
84. Hayes, JD and Flanagan, JU and Jowsey, IR. (2004) Glutathione transferases Annu Rev Pharmacol Toxicol, 17, pp. 17.
85. Ryoo, K and Huh, SH and Lee, YH and Yoon, KW and Cho, SG and Choi, EJ. (2004) Negative regulation of MEKK1-induced signaling by glutathione S-transferase Mu J Biol Chem, 279, pp. 43589-43594. Epub 42004 Aug 43586
86. Dorion, S and Lambert, H and Landry, J. (2002) Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1 J Biol Chem, 277, pp. 30792-30797. Epub 32002 Jun 30719
87. Henderson, CJ and Wolf, CR and Kitteringham, N and Powell, H and Otto, D and Park, BK. (2000) Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi Proc Natl Acad Sci USA, 97, pp. 12741-12745.
88. Otto-Knapp, R and Jurgovsky, K and Schierhorn, K and Kunkel, G. (2003) Antioxidative enzymes in human nasal mucosa after exposure to ozone. Possible role of GSTM1 deficiency Inflamm Res, 52, pp. 51-55.
89. Kubisch, HM and Wang, J and Bray, TM and Phillipss, JP. (1997) Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress Diabetes, 46, pp. 1563-1566.
90. Slonim, AE and Surber, ML and Page, DL and Sharp, RA and Burr, IM. (1983) Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes J Clin Investig, 71, pp. 1282-1288.
91. Dominguez, C and Ruiz, E and Gussinye, M and Carrascosa, A. (1998) Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents Diabetes Care, 21, pp. 1736-1742.
92. Strokov, IA and Bursa, TR and Drepa, OI and Zotova, EV and Nosikov, VV and Ametov, AS. (2003) Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: A population-based case-control study Acta Diabetol, 40, pp. S375-S379.
93. Watanabe, I and Tomita, A and Shimizu, M and Sugawara, M and Yasumo, H and Koishi, R and Takahashi, T and Miyoshi, K and Nakamura, K and Izumi, T and Matsushita, Y and Furukawa, H and Haruyama, H and Koga, T. (2003) A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus Clin Pharmacol Ther, 73, pp. 435-455.
94. Fujita, H and Narita, T and Meguro, H and Shimotomai, T and Kitazato, H and Kagaya, E and Sugasawa, H and Hanyu, O and Suzuki, K and Ito, S. (2000) No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients Ren Fail, 22, pp. 479-486.
95. Zotova, EV and Savost'ianov, KV and Chistiakov, DA and Bursa, TR and Galeev, IV and Strokov, IA and Nosikov, VV. (2004) Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus Mol Biol (Mosk), 38, pp. 244-249.
96. Abbas, A and Delvinquiere, K and Lechevrel, M and Lebailly, P and Gauduchon, P and Launoy, G and Sichel, F. (2004) GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma World J Gastroenterol, 10, pp. 3389-3393.